Fig. 1
From: Plasma markers in pulmonary hypertension subgroups correlate with patient survival
Inflammatory markers in plasma of treatment-naïve PAH and CTEPH patients at diagnosis. The indicated inflammatory markers were measured in plasma samples from 50 PAH patients (16 IPAH, 24 CTD-PAH and 10 CHD-PAH), 37 CTEPH patients at diagnosis and 18 healthy controls (HC) by ELISA. Data are shown as symbols for individual patients or HCs; horizontal bars represent mean values. Statistical analysis was performed using a Kruskal–Wallis test combined with a Dunn’s multiple comparison test. * = p < 0.05